Incidental Genomics

NAActive, not recruitingINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

January 15, 2021

Study Completion Date

October 1, 2027

Conditions
Cancer
Interventions
OTHER

Incidental Genomic Sequencing Results

"Patient will receive GS results related to their primary indication (cancer), as well as the option to learn incidental GS results. Incidental results will be categorized into five bins based on Berg et al.'s framework (medically actionable and pharmacogenetic, common disease SNPs, Mendelian conditions, early-onset brain diseases, and carrier status). In pre-test counseling, patients will have the option to select which bins of incidental results they would like to learn, if any."

OTHER

GS Results for Primary Indications only

Patients will receive GS results related to the primary indication (cancer) only.

Trial Locations (3)

Unknown

Mount Sinai Hospital, Toronto

Princess Margret Cancer Centre, Toronto

Sunnybrook Hospital, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT03597165 - Incidental Genomics | Biotech Hunter | Biotech Hunter